SEC Info - Medicines Co/DE - ‘S-3ASR’ on 8/12/13

SEC Info℠

Home

Help

Please Sign In

Medicines Co/DE – ‘S-3ASR’ on 8/12/13 – EX-23.2

On: Monday, 8/12/13, at 4:12pm ET · Effective: 8/12/13 · Accession #: 1047469-13-8368 · File #: 333-190568

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 8/12/13  Medicines Co/DE                   S-3ASR      8/12/13   10:1.4M                                   Merrill Corp/New/FA

Automatic Shelf Registration Statement for Securities of a Well-Known Seasoned Issuer — Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3ASR      Automatic Shelf Registration Statement for          HTML    253K 
                          Securities of a Well-Known Seasoned                    
                          Issuer                                                 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML    356K 
 3: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    373K 
 4: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     48K 
 5: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     48K 
 6: EX-5.1      Opinion re: Legality                                HTML     46K 
 7: EX-12       Statement re: Computation of Ratios                 HTML     16K 
 8: EX-23.1     Consent of Experts or Counsel                       HTML      8K 
 9: EX-23.2     Consent of Experts or Counsel                       HTML      8K 
10: EX-23.3     Consent of Experts or Counsel                       HTML      8K

EX-23.2 — Consent of Experts or Counsel

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 23.2

CONSENT OF INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of The Medicines Company for the registration of Debt Securities, Common Stock, Preferred Stock, Depositary Shares, Purchase Contracts, Purchase Units, and Warrants and to the incorporation by reference therein of our report dated May 14, 2013, with respect to the consolidated financial statements of Incline Therapeutics, Inc. as of December 31, 2012 and 2011 and for the years then ended and for the period from December 3, 2009 (inception) through December 31, 2012, included in Form 8-K of The Medicines Company, as filed on August 12, 2013 with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Redwood City, CA

August 12, 2013

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-3ASR’ Filing	Date	Other Filings

Filed on / Effective on:	8/12/13	424B5, 8-K
	5/14/13
	12/31/12	10-K, 5
	12/31/11	10-K/A
	12/3/09
		List all Filings

↑Top

Filing Submission 0001047469-13-008368 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)